LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 95

Search options

  1. Article: The ATPase Inhibitory Factor 1 (IF1) Contributes to the Warburg Effect and Is Regulated by Its Phosphorylation in S39 by a Protein Kinase A-like Activity.

    Cuezva, José M / Domínguez-Zorita, Sonia

    Cancers

    2024  Volume 16, Issue 5

    Abstract: The relevant role played by the ATPase Inhibitory Factor 1 (IF1) as a physiological in vivo inhibitor of mitochondrial ATP synthase in cancer and non-cancer cells, and in the mitochondria of different mouse tissues, as assessed in different genetic loss- ...

    Abstract The relevant role played by the ATPase Inhibitory Factor 1 (IF1) as a physiological in vivo inhibitor of mitochondrial ATP synthase in cancer and non-cancer cells, and in the mitochondria of different mouse tissues, as assessed in different genetic loss- and gain-of-function models of IF1 has been extensively documented. In this review we summarize our findings and those of others that favor the implication of IF1 in metabolic reprogramming to an enhanced glycolytic phenotype, which is mediated by its binding and inhibition of the ATP synthase. Moreover, we emphasize that IF1 is phosphorylated in vivo in its S39 by the c-AMP-dependent PKA activity of mitochondria to render an inactive inhibitor that is unable to interact with the enzyme, thus triggering the activation of ATP synthase. Overall, we discuss and challenge the results that argue against the role of IF1 as in vivo inhibitor of mitochondrial ATP synthase and stress that IF1 cannot be regarded solely as a pro-oncogenic protein because in some prevalent carcinomas, it prevents metastatic disease.
    Language English
    Publishing date 2024-02-29
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2527080-1
    ISSN 2072-6694
    ISSN 2072-6694
    DOI 10.3390/cancers16051014
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: The Mitochondrial ATP Synthase/IF1 Axis in Cancer Progression: Targets for Therapeutic Intervention.

    Domínguez-Zorita, Sonia / Cuezva, José M

    Cancers

    2023  Volume 15, Issue 15

    Abstract: Cancer poses a significant global health problem with profound personal and economic implications on National Health Care Systems. The reprograming of metabolism is a major trait of the cancer phenotype with a clear potential for developing effective ... ...

    Abstract Cancer poses a significant global health problem with profound personal and economic implications on National Health Care Systems. The reprograming of metabolism is a major trait of the cancer phenotype with a clear potential for developing effective therapeutic strategies to combat the disease. Herein, we summarize the relevant role that the mitochondrial ATP synthase and its physiological inhibitor, ATPase Inhibitory Factor 1 (IF1), play in metabolic reprogramming to an enhanced glycolytic phenotype. We stress that the interplay in the ATP synthase/IF1 axis has additional functional roles in signaling mitohormetic programs, pro-oncogenic or anti-metastatic phenotypes depending on the cell type. Moreover, the same axis also participates in cell death resistance of cancer cells by restrained mitochondrial permeability transition pore opening. We emphasize the relevance of the different post-transcriptional mechanisms that regulate the specific expression and activity of ATP synthase/IF1, to stimulate further investigations in the field because of their potential as future targets to treat cancer. In addition, we review recent findings stressing that mitochondria metabolism is the primary altered target in lung adenocarcinomas and that the ATP synthase/IF1 axis of OXPHOS is included in the most significant signature of metastatic disease. Finally, we stress that targeting mitochondrial OXPHOS in pre-clinical mouse models affords a most effective therapeutic strategy in cancer treatment.
    Language English
    Publishing date 2023-07-25
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2527080-1
    ISSN 2072-6694
    ISSN 2072-6694
    DOI 10.3390/cancers15153775
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Book ; Conference proceedings: Endocrine and biochemical development of the fetus and neonate

    Cuezva, José M.

    [proceedings of the annual meeting of the Perinatal Biochemical Group of the Spanish Biochemical Society, on Biochemical Development of the Fetus and Neonate, held December 15 - 16, 1988, in Madrid, Spain]

    (Reproductive biology)

    1990  

    Institution Spanish Biochemical Society / Perinatal Biochemical Group
    Event/congress Meeting on Biochemical Development of the Fetus and Neonate (1988, Madrid)
    Author's details ed. by José M. Cuezva
    Series title Reproductive biology
    Keywords Endocrine Glands / physiology / congresses ; Fetal Development / congresses ; Fetus / physiology / congresses ; Infant, Newborn / congresses ; Fetalentwicklung ; Endokrinium ; Perinatalperiode ; Physiologische Chemie ; Neugeborenes ; Entwicklung ; Biochemie
    Subject Biologische Chemie ; Fetogenese ; Fetus ; Ursprung ; Entwicklungsstadium ; Neugeborene ; Chemische Physiologie ; Biochemische Medizin ; Medizinische Biochemie ; Perinatale Phase ; Endokrines System
    Size IX, 316 S. : Ill., graph. Darst.
    Publisher Plenum Pr
    Publishing place New York u.a.
    Publishing country United States
    Document type Book ; Conference proceedings
    HBZ-ID HT003679240
    ISBN 0-306-43675-2 ; 978-0-306-43675-8
    Database Catalogue ZB MED Medicine, Health

    Kategorien

  4. Article ; Online: Reprogramming Oxidative Phosphorylation in Cancer: A Role for RNA-Binding Proteins.

    Esparza-Moltó, Pau B / Cuezva, José M

    Antioxidants & redox signaling

    2020  Volume 33, Issue 13, Page(s) 927–945

    Abstract: Significance: ...

    Abstract Significance:
    MeSH term(s) Animals ; Cell Transformation, Neoplastic/genetics ; Cell Transformation, Neoplastic/metabolism ; Disease Susceptibility ; Energy Metabolism ; Gene Expression Regulation, Enzymologic ; Gene Expression Regulation, Neoplastic ; Glycolysis ; Humans ; Mitochondria/genetics ; Mitochondria/metabolism ; Neoplasms/etiology ; Neoplasms/metabolism ; Neoplasms/pathology ; Organ Specificity ; Oxidative Phosphorylation ; RNA-Binding Proteins/genetics ; RNA-Binding Proteins/metabolism
    Chemical Substances RNA-Binding Proteins
    Language English
    Publishing date 2020-01-30
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 1483836-9
    ISSN 1557-7716 ; 1523-0864
    ISSN (online) 1557-7716
    ISSN 1523-0864
    DOI 10.1089/ars.2019.7988
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: The ATPase Inhibitory Factor 1 is a Tissue-Specific Physiological Regulator of the Structure and Function of Mitochondrial ATP Synthase: A Closer Look Into Neuronal Function.

    Domínguez-Zorita, Sonia / Romero-Carramiñana, Inés / Cuezva, José M / Esparza-Moltó, Pau B

    Frontiers in physiology

    2022  Volume 13, Page(s) 868820

    Abstract: The ATP synthase is an essential multifunctional enzyme complex of mitochondria that produces most of cellular ATP, shapes the structure of the inner membrane into cristae and regulates the signals that control cell fate or demise. The ATPase Inhibitory ... ...

    Abstract The ATP synthase is an essential multifunctional enzyme complex of mitochondria that produces most of cellular ATP, shapes the structure of the inner membrane into cristae and regulates the signals that control cell fate or demise. The ATPase Inhibitory Factor 1 (IF1) functions
    Language English
    Publishing date 2022-03-18
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2564217-0
    ISSN 1664-042X
    ISSN 1664-042X
    DOI 10.3389/fphys.2022.868820
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: IF1 promotes oligomeric assemblies of sluggish ATP synthase and outlines the heterogeneity of the mitochondrial membrane potential.

    Romero-Carramiñana, Inés / Esparza-Moltó, Pau B / Domínguez-Zorita, Sonia / Nuevo-Tapioles, Cristina / Cuezva, José M

    Communications biology

    2023  Volume 6, Issue 1, Page(s) 836

    Abstract: The coexistence of two pools of ATP synthase in mitochondria has been largely neglected despite in vitro indications for the existence of reversible active/inactive state transitions in the F1-domain of the enzyme. Herein, using cells and mitochondria ... ...

    Abstract The coexistence of two pools of ATP synthase in mitochondria has been largely neglected despite in vitro indications for the existence of reversible active/inactive state transitions in the F1-domain of the enzyme. Herein, using cells and mitochondria from mouse tissues, we demonstrate the existence in vivo of two pools of ATP synthase: one active, the other IF1-bound inactive. IF1 is required for oligomerization and inactivation of ATP synthase and for proper cristae formation. Immunoelectron microscopy shows the co-distribution of IF1 and ATP synthase, placing the inactive "sluggish" ATP synthase preferentially at cristae tips. The intramitochondrial distribution of IF1 correlates with cristae microdomains of high membrane potential, partially explaining its heterogeneous distribution. These findings support that IF1 is the in vivo regulator of the active/inactive state transitions of the ATP synthase and suggest that local regulation of IF1-ATP synthase interactions is essential to activate the sluggish ATP synthase.
    MeSH term(s) Mice ; Animals ; Mitochondrial Proton-Translocating ATPases/genetics ; Membrane Potential, Mitochondrial ; Mitochondria/metabolism ; Mitochondrial Membranes/metabolism ; Adenosine Triphosphate/metabolism
    Chemical Substances Mitochondrial Proton-Translocating ATPases (EC 3.6.3.-) ; Adenosine Triphosphate (8L70Q75FXE)
    Language English
    Publishing date 2023-08-12
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ISSN 2399-3642
    ISSN (online) 2399-3642
    DOI 10.1038/s42003-023-05214-1
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: An ETFDH-driven metabolon supports OXPHOS efficiency in skeletal muscle by regulating coenzyme Q homeostasis.

    Herrero Martín, Juan Cruz / Salegi Ansa, Beñat / Álvarez-Rivera, Gerardo / Domínguez-Zorita, Sonia / Rodríguez-Pombo, Pilar / Pérez, Belén / Calvo, Enrique / Paradela, Alberto / Miguez, David G / Cifuentes, Alejandro / Cuezva, José M / Formentini, Laura

    Nature metabolism

    2024  Volume 6, Issue 2, Page(s) 209–225

    Abstract: Coenzyme Q (Q) is a key lipid electron transporter, but several aspects of its biosynthesis and redox homeostasis remain undefined. Various flavoproteins reduce ubiquinone (oxidized form of Q) to ubiquinol ( ... ...

    Abstract Coenzyme Q (Q) is a key lipid electron transporter, but several aspects of its biosynthesis and redox homeostasis remain undefined. Various flavoproteins reduce ubiquinone (oxidized form of Q) to ubiquinol (QH
    MeSH term(s) Animals ; Mice ; Ubiquinone/metabolism ; Ubiquinone/therapeutic use ; Oxidative Phosphorylation ; Electron-Transferring Flavoproteins/genetics ; Electron-Transferring Flavoproteins/metabolism ; Muscle, Skeletal/metabolism ; Lipids ; Homeostasis
    Chemical Substances Ubiquinone (1339-63-5) ; Electron-Transferring Flavoproteins ; Lipids
    Language English
    Publishing date 2024-01-19
    Publishing country Germany
    Document type Journal Article
    ISSN 2522-5812
    ISSN (online) 2522-5812
    DOI 10.1038/s42255-023-00956-y
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Metabolic reprogramming and disease progression in cancer patients.

    Torresano, Laura / Nuevo-Tapioles, Cristina / Santacatterina, Fulvio / Cuezva, José M

    Biochimica et biophysica acta. Molecular basis of disease

    2020  Volume 1866, Issue 5, Page(s) 165721

    Abstract: Genomics has contributed to the treatment of a fraction of cancer patients. However, there is a need to profile the proteins that define the phenotype of cancer and its pathogenesis. The reprogramming of metabolism is a major trait of the cancer ... ...

    Abstract Genomics has contributed to the treatment of a fraction of cancer patients. However, there is a need to profile the proteins that define the phenotype of cancer and its pathogenesis. The reprogramming of metabolism is a major trait of the cancer phenotype with great potential for prognosis and targeted therapy. This review overviews the major changes reported in the steady-state levels of proteins of metabolism in primary carcinomas, paying attention to those enzymes that correlate with patients' survival. The upregulation of enzymes of glycolysis, pentose phosphate pathway, lipogenesis, glutaminolysis and the antioxidant defense is concurrent with the downregulation of mitochondrial proteins involved in oxidative phosphorylation, emphasizing the potential of mitochondrial metabolism as a promising therapeutic target in cancer. We stress that high-throughput quantitative expression profiling of differentially expressed proteins in large cohorts of carcinomas paired with normal tissues will accelerate translation of metabolism to a successful personalized medicine in cancer.
    MeSH term(s) Animals ; Antineoplastic Agents/pharmacology ; Antineoplastic Agents/therapeutic use ; Biomarkers, Tumor/genetics ; Biomarkers, Tumor/metabolism ; Carcinogenesis/drug effects ; Carcinogenesis/metabolism ; Carcinoma/drug therapy ; Carcinoma/genetics ; Carcinoma/mortality ; Carcinoma/pathology ; Disease Models, Animal ; Disease Progression ; Down-Regulation ; Energy Metabolism/drug effects ; Energy Metabolism/genetics ; Gene Expression Regulation, Neoplastic ; Glycolysis/drug effects ; Glycolysis/genetics ; Humans ; Lipogenesis/drug effects ; Lipogenesis/genetics ; Mitochondria/drug effects ; Mitochondria/enzymology ; Mutation ; Oxidative Phosphorylation/drug effects ; Oxidative Stress/drug effects ; Oxidative Stress/genetics ; Prognosis ; Reactive Oxygen Species/metabolism ; Survival Rate ; Up-Regulation
    Chemical Substances Antineoplastic Agents ; Biomarkers, Tumor ; Reactive Oxygen Species
    Language English
    Publishing date 2020-02-11
    Publishing country Netherlands
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 60-7
    ISSN 1879-260X ; 1879-2596 ; 1872-8006 ; 1879-2642 ; 1879-2618 ; 1879-2650 ; 0006-3002 ; 0005-2728 ; 0005-2736 ; 0304-4165 ; 0167-4838 ; 1388-1981 ; 0167-4889 ; 0167-4781 ; 0304-419X ; 1570-9639 ; 0925-4439 ; 1874-9399
    ISSN (online) 1879-260X ; 1879-2596 ; 1872-8006 ; 1879-2642 ; 1879-2618 ; 1879-2650
    ISSN 0006-3002 ; 0005-2728 ; 0005-2736 ; 0304-4165 ; 0167-4838 ; 1388-1981 ; 0167-4889 ; 0167-4781 ; 0304-419X ; 1570-9639 ; 0925-4439 ; 1874-9399
    DOI 10.1016/j.bbadis.2020.165721
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: A Review of the Inhibition of the Mitochondrial ATP Synthase by IF1

    García-Aguilar, Ana / Cuezva, José M

    Frontiers in physiology

    2018  Volume 9, Page(s) 1322

    Abstract: The ATPase Inhibitory Factor 1 (IF1) is the physiological inhibitor of the mitochondrial ATP synthase. Herein, we summarize the regulation of the expression and activity of IF1 as a main driver of the activity of oxidative phosphorylation (OXPHOS) in ... ...

    Abstract The ATPase Inhibitory Factor 1 (IF1) is the physiological inhibitor of the mitochondrial ATP synthase. Herein, we summarize the regulation of the expression and activity of IF1 as a main driver of the activity of oxidative phosphorylation (OXPHOS) in mammalian tissues. We emphasize that the expression of IF1, which is a mitochondrial protein with very short half-life, is tissue-specifically expressed and primarily controlled at posttranscriptional levels. Inhibition of the activity of IF1 as inhibitor of the ATP synthase under normal physiological conditions is exerted by phosphorylation of S39 by a cAMP-dependent PKA-like activity of mitochondria in response to different physiological cues. Conditional tissue-specific transgenic mice overexpressing IF1 in colon, or a mutant active version of IF1 (IF1-H49K) in liver or in neurons, revealed the inhibition of the ATP synthase and the reprograming of energy metabolism to an enhanced glycolysis. In the IF1-H49K models, the assembly/activity of complex IV and the superassembly of complex V are also affected. Moreover, the IF1-mediated inhibition of the ATP synthase generates a reactive oxygen species (mtROS) signal that switches on the expression of nuclear genes that facilitate adaptation to a restrained OXPHOS. In contrast to normal mice, metabolically preconditioned animals are partially protected from the action of cytotoxic agents by upgrading the activation of stress kinases and transcription factors involved in resolving metabolic adaptation, the antioxidant response, cell survival, and the immune response of the tissue microenvironment. Altogether, we stress a fundamental physiological function for the ATP synthase and its inhibitor in mitohormesis.
    Language English
    Publishing date 2018-09-19
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2564217-0
    ISSN 1664-042X
    ISSN 1664-042X
    DOI 10.3389/fphys.2018.01322
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: The Role of Mitochondrial H

    Esparza-Moltó, Pau B / Cuezva, José M

    Frontiers in oncology

    2018  Volume 8, Page(s) 53

    Abstract: Cancer cells reprogram energy metabolism by boosting aerobic glycolysis as a main pathway for the provision of metabolic energy and of precursors for anabolic purposes. Accordingly, the relative expression of the catalytic subunit of the mitochondrial ... ...

    Abstract Cancer cells reprogram energy metabolism by boosting aerobic glycolysis as a main pathway for the provision of metabolic energy and of precursors for anabolic purposes. Accordingly, the relative expression of the catalytic subunit of the mitochondrial H
    Language English
    Publishing date 2018-03-07
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2649216-7
    ISSN 2234-943X
    ISSN 2234-943X
    DOI 10.3389/fonc.2018.00053
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top